Manjool Shah, MD, clinical associate professor of ophthalmology and visual sciences for the Kellogg Eye Center, discussed how ...
Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
The FDA approved a fixed-dose combination of carbachol and brimonidine tartrate for presbyopia, offering a noninvasive alternative to glasses or surgery. Phase 3 trials demonstrated superior ...
Combining two eye drops that have been on the market for at least 30 years each has earned Tenpoint Therapeutics an FDA ...
The FDA approved Yuvezzi, an eye drop for the treatment of presbyopia, with broad U.S. availability expected in the second quarter, according to a press release from Tenpoint Therapeutics. Yuvezzi ...
Full Sail University Student Dinara Akbayeva Awarded $1,000 Scholarship For Her Perseverance After Life-Changing Auto ...
For patients with glaucoma, a high pillow position is associated with increased intraocular pressure (IOP) and reduced ocular ...
High axial myopia is linked to increased prevalence of nonglaucomatous, glaucoma-like, and glaucomatous optic neuropathies.
The FDA approved Yuvezzi, a fixed-dose combination eye drop of carbachol and brimonidine tartrate, for the treatment of presbyopia in adult patients.